tradingkey.logo

Alpha Teknova Inc

TKNO
2.250USD
-0.050-2.17%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
120.43MValor de mercado
PerdaP/L TTM

Alpha Teknova Inc

2.250
-0.050-2.17%

Mais detalhes de Alpha Teknova Inc Empresa

Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary product categories, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. It supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.

Informações de Alpha Teknova Inc

Código da empresaTKNO
Nome da EmpresaAlpha Teknova Inc
Data de listagemJun 25, 2021
CEOGunstream (Stephen)
Número de funcionários173
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 25
Endereço2451 Bert Drive
CidadeHOLLISTER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal95023
Telefone18316371100
Sitehttps://www.teknova.com/
Código da empresaTKNO
Data de listagemJun 25, 2021
CEOGunstream (Stephen)

Executivos da empresa Alpha Teknova Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Irene Davis
Ms. Irene Davis
Director
Director
1.69M
--
Mr. Stephen Gunstream
Mr. Stephen Gunstream
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
243.50K
+28750.00%
Mr. Alexander Vos
Mr. Alexander Vos
Independent Director
Independent Director
126.72K
+54300.00%
Mr. Damon Terrill
Mr. Damon Terrill
Chief Compliance Officer, General Counsel
Chief Compliance Officer, General Counsel
41.03K
--
Ms. Martha J. Demski
Ms. Martha J. Demski
Independent Director
Independent Director
25.07K
-8000.00%
Dr. Paul D. Grossman
Dr. Paul D. Grossman
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
9.21K
--
Mr. Matthew C. Lowell
Mr. Matthew C. Lowell
Chief Financial Officer
Chief Financial Officer
--
--
Alex Herzick
Alex Herzick
Director
Director
--
--
Mr. J. Matthew Mackowski
Mr. J. Matthew Mackowski
Director
Director
--
--
Ms. Brett M. Robertson
Ms. Brett M. Robertson
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Irene Davis
Ms. Irene Davis
Director
Director
1.69M
--
Mr. Stephen Gunstream
Mr. Stephen Gunstream
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
243.50K
+28750.00%
Mr. Alexander Vos
Mr. Alexander Vos
Independent Director
Independent Director
126.72K
+54300.00%
Mr. Damon Terrill
Mr. Damon Terrill
Chief Compliance Officer, General Counsel
Chief Compliance Officer, General Counsel
41.03K
--
Ms. Martha J. Demski
Ms. Martha J. Demski
Independent Director
Independent Director
25.07K
-8000.00%
Dr. Paul D. Grossman
Dr. Paul D. Grossman
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
9.21K
--

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Lab Essentials
8.31M
79.47%
Clinical Solutions
1.71M
16.32%
Other
440.00K
4.21%
Por RegiãoUSD
Nome
Receita
Proporção
United States
9.83M
94.05%
International
622.00K
5.95%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Lab Essentials
8.31M
79.47%
Clinical Solutions
1.71M
16.32%
Other
440.00K
4.21%

Distribuição de ações

Atualizado em: dom, 1 de fev
Atualizado em: dom, 1 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Telegraph Hill Partners
70.46%
Davis (Ted)
3.53%
Davis (Irene)
3.15%
Balyasny Asset Management LP
1.84%
Roubaix Capital, LLC
1.56%
Outro
19.46%
Investidores
Investidores
Proporção
Telegraph Hill Partners
70.46%
Davis (Ted)
3.53%
Davis (Irene)
3.15%
Balyasny Asset Management LP
1.84%
Roubaix Capital, LLC
1.56%
Outro
19.46%
Tipos de investidores
Investidores
Proporção
Private Equity
70.46%
Individual Investor
10.71%
Investment Advisor
4.95%
Investment Advisor/Hedge Fund
4.91%
Hedge Fund
2.15%
Research Firm
0.65%
Bank and Trust
0.07%
Pension Fund
0.04%
Outro
6.05%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
154
44.56M
83.25%
-3.53M
2025Q3
143
45.32M
84.68%
-1.67M
2025Q2
134
49.86M
93.29%
-910.00K
2025Q1
159
49.02M
94.72%
+9.59M
2024Q4
142
49.19M
92.33%
+11.09M
2024Q3
142
47.90M
89.93%
+8.81M
2024Q2
140
36.69M
87.73%
-3.53M
2024Q1
145
36.60M
90.14%
-2.50M
2023Q4
149
35.47M
91.35%
-3.28M
2023Q3
155
35.09M
90.51%
+4.53M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Telegraph Hill Partners
37.72M
70.46%
--
--
Apr 22, 2025
Davis (Ted)
1.89M
3.53%
--
--
Apr 22, 2025
Davis (Irene)
1.69M
3.15%
--
--
Apr 22, 2025
Balyasny Asset Management LP
987.23K
1.84%
-13.26K
-1.33%
Sep 30, 2025
Roubaix Capital, LLC
833.82K
1.56%
+393.88K
+89.53%
Sep 30, 2025
Mackowski J Matthew
820.81K
1.53%
--
--
Apr 22, 2025
Lowell (Matthew)
820.81K
1.53%
+701.77K
+589.51%
Apr 22, 2025
UBS Financial Services, Inc.
1.50M
2.8%
-84.17K
-5.31%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
608.05K
1.14%
-7.86K
-1.28%
Sep 30, 2025
The Vanguard Group, Inc.
625.55K
1.17%
-26.63K
-4.08%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
ProShares Nanotechnology ETF
0.52%
Invesco Nasdaq Biotechnology ETF
0.03%
ProShares Ultra Nasdaq Biotechnology
0.03%
iShares Biotechnology ETF
0.01%
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Growth ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
Ver Mais
ProShares Nanotechnology ETF
Proporção0.52%
Invesco Nasdaq Biotechnology ETF
Proporção0.03%
ProShares Ultra Nasdaq Biotechnology
Proporção0.03%
iShares Biotechnology ETF
Proporção0.01%
iShares Micro-Cap ETF
Proporção0.01%
iShares Russell 2000 Growth ETF
Proporção0%
Dimensional US Core Equity 1 ETF
Proporção0%
iShares Russell 2000 ETF
Proporção0%
Proshares Ultra Russell 2000
Proporção0%
ProShares UltraPro Russell2000
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI